A ground-breaking case in the High Court will decide this week whether the UK’s only gender identity development service (GIDS) for under-18s will be allowed to continue to prescribe puberty blockers for children as young as 10-years-old. The case against the Tavistock and Portman NHS trust, which runs GIDs, is currently conducting its own internal review as a response to the growing controversy surrounding its practice.